The microbial code and cancer immunotherapy outcome

The contribution of the gut microbiome to immune responsiveness is largely unknown. In a recent Nature Medicine article, Stein-Thoeringer et al. assess the microbiome configuration before cancer immunotherapy and determine the impact of antibiotic-masked microbial features on therapy's effectiveness. This provides a framework for identifying microbial signatures to inform clinical strategies.

Automated summary

In a recent article published in Nature Medicine, Stein-Thoeringer et al. examine the gut microbiome configuration prior to cancer immunotherapy and investigate the effects of antibiotic-masked microbial features on the therapy's effectiveness. This study offers a framework for identifying microbial signatures to guide clinical strategies.